+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy), Guidance (Stereotactic, Ultrasound), End User (Hospital) & Region - Forecast to 2028

  • PDF Icon

    Report

  • 229 Pages
  • October 2023
  • Region: Global
  • Markets and Markets
  • ID: 5897397
Description Jump to:

The global biopsy devices market is projected to reach USD 12.6 billion by 2028 from USD 6.6 billion in 2023, at a CAGR of 14.0% from 2023 to 2028. Factors such as the the rising incidence of cancer and other chronic diseases has spurred the need for more frequent and accurate tissue sampling. Moreover, increased awareness of the importance of early disease detection and personalized medicine has driven demand for advanced biopsy devices.

The Needle based biopsy instruments segment of product segment l held the largest share of the market in 2022

Based on product, the biopsy devices market is segmented into needle based biopsy instruments, localization wire, biopsy forceps, procedure tray, biopsy table and other products. The needle based biopsy instruments segment held a major share of the market. advancements in needle biopsy technologies, such as improved guidance systems and the development of more specialized needles for different tissue types, have increased the accuracy and reliability of these procedures, further driving their adoption.

The breast biopsy segment is projected to register the highest CAGR during the forecast period

Based on application, the biopsy devices market is segmented into breast, lung, kidney, colorectal, bone marrow, prostate and other applications. The breast biopsy segment accounted for the largest market share in 2022. breast cancer remains one of the most prevalent cancers globally, emphasizing the critical role of early and accurate diagnosis. As breast cancer awareness and screening programs expand, the demand for biopsy procedures to confirm diagnoses and determine treatment strategies is on the rise.

The diagnostic imaging centers segment for end user segment is projected to register a significant CAGR during the forecast period

On the basis of end user, the biopsy devices market is segmented into hospitals and breast care centers, diagnostic imaging cneters, academic and research institutes. The diagnostic imaging centers segment accounted for the significant share of the biopsy devices market in 2022. By advanced biopsy deives diagnostic imaging centers can provide more accurate and reliable diagnoses, leading to better treatment planning and improved patient outcomes. Moreover, the versatility of biopsy devices imaging enables these centers to cater to a wide range of medical specialties, effectively serving patients with diverse healthcare needs.

The market in the North America region is expected to witness the highest growth during the forecast period

The biopsy devices market in the North America region is expected to register a CAGR during the forecast period, primarily due to the high healthcare spending in the region, rising prevalence of target diseases, increasing research activities, growing number of cosmetic surgeries, and technological advancements in imaging systems.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 - 48%, Tier 2 - 36%, and Tier 3 - 16%
  • By Designation: Director - level - 14%, C - level - 10%, and Others - 76%
  • By Region: North America - 40%, Europe - 32%, Asia Pacific - 20%, Latin America - 5%, and the Middle East & Africa - 3%

The prominent players in the biopsy devices market are Becton, Dickinson and Company (US), Cook Group Incorporated (US), Devicor Medical Products, Inc., (Leica Biosystems) (US), Hologic, Inc. (US), Argon Medical Devices (US), B. Braun SE (Germany), Cardinal Health, Inc. (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (US), and Medtronic plc (Ireland) among others.

Research Coverage

This report studies the biopsy devices market based on technology, display, portability, component, application, enduser, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall biopsy devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (rising target patient population, growing adoption of biopsy devices imaging devices, technological advancement, and increasing investment, funds, and grants by public-private organizations), restraints (high capital and operational cost, unfavorable regulatory guidelines), opportunities (improving healthcare infrastructure across emerging countries, biopsy devices utilization for breast imaging, promising product pipeline), and challenges (availability of alternate imaging technologies) influencing the growth of the biopsy devices market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the biopsy devices market
  • Market Development: Comprehensive information about lucrative markets-the report analyses the biopsy devices market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the biopsy devices market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Becton, Dickinson and Company (US), Cook Group Incorporated (US), Devicor Medical Products, Inc., (Leica Biosystems) (US), Hologic, Inc. (US), Argon Medical Devices (US), B. Braun SE (Germany), Cardinal Health, Inc. (US), Olympus Corporation (Japan), and Boston Scientific Corporation (US) among others.

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.2.2 Market Segmentation
1.2.3 Years Considered
1.2.4 Currency Considered
1.3 Stakeholders
1.4 Summary of Changes
1.5 Recession Impact

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Research
2.1.2 Primary Research
2.1.2.1 Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
Figure 2 Breakdown of Primary Interviews: Supply and Demand-Side Participants
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.2 Market Size Estimation Methodology
Figure 4 Research Methodology: Hypothesis Building
2.2.1 Bottom-Up Approach
2.2.1.1 Approach 1: Company Revenue Estimation Approach
Figure 5 Market Size Estimation for Needle-Based Biopsy Devices and Accessory Market
Figure 6 Market Size Estimation for Liquid Biopsy Approach 1 (Company Revenue Estimation)
Figure 7 Revenue Share Analysis: Illustrative Example of Becton, Dickinson, and Company
2.2.1.2 Approach 2: Customer-Based Market Estimation
2.2.1.3 Top-Down Approach of Biopsy Devices Market
2.2.1.4 Approach 3: CAGR Projections
Figure 8 CAGR Projections: Supply-Side Analysis
2.2.2 End-user-Based Market Size Estimation
Figure 9 Biopsy Devices Market: End-user-Based Estimation
2.3 Market Breakdown and Data Triangulation
Figure 10 Data Triangulation Methodology
2.3.1 Market Share Assessment
2.4 Research Assumptions
2.5 Growth Rate Assumptions
2.6 Research Limitations
2.6.1 Scope-Related Limitations
2.6.2 Methodology-Related Limitations
2.7 Risk Assessment
2.7.1 Risk Assessment Analysis
2.8 Recession Impact Analysis

3 Executive Summary
Figure 11 Biopsy Devices Market, by Product, 2023 Vs. 2028 (USD Million)
Figure 12 Biopsy Devices Market, by Application, 2023 Vs. 2028 (USD Million)
Figure 13 Biopsy Devices Market, by End-user, 2023 Vs. 2028 (USD Million)
Figure 14 Geographical Snapshot: Biopsy Devices Market

4 Premium Insights
4.1 Biopsy Devices Market Overview
Figure 15 Growing Demand for Minimally Invasive Surgery to Drive Market
4.2 North America: Biopsy Devices Market, by Product, 2023 Vs. 2028 (USD Million)
Figure 16 Liquid Biopsy Instruments to Dominate North American Market in 2023
4.3 Asia-Pacific: Biopsy Devices Market, by End-user, 2023 Vs. 2028 (USD Million)
Figure 17 Hospitals & Breast Care Centers to Dominate Asia-Pacific Market in 2023
4.4 Europe: Biopsy Devices Market, by Guidance Technique, 2023 Vs. 2028 (USD Million)
Figure 18 Non-Image-Guided Biopsy Segment to Dominate European Market During Forecast Period
4.5 Biopsy Devices Market: Geographic Growth Opportunities
Figure 19 Us to Witness Highest Growth During Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 20 Drivers, Restraints, Opportunities, and Challenges: Biopsy Devices Market
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Cancer
5.2.1.2 Increasing Preference for Minimally Invasive Surgeries
5.2.1.3 Initiatives Undertaken by Governments and Global Health Organizations
5.2.1.4 Increased Number of Hospitals and Diagnostic Centers
5.2.1.5 Improved Reimbursement Scenario
5.2.2 Restraints
5.2.2.1 Increasing Product Recalls
Table 1 Indicative List of Fda Product Recalls for Biopsy Devices (2020-2021)
5.2.2.2 High Risk of Infections for Patients
5.2.3 Opportunities
5.2.3.1 Technological Innovations in Biopsy Devices
5.2.3.2 Growing Investments in Emerging Economies
5.2.4 Challenges
5.2.4.1 Underdeveloped Healthcare Infrastructure in Emerging Economies
5.3 Porter's Five Forces Analysis
Table 2 Porter's Five Forces Analysis: Biopsy Devices Market
5.3.1 Threat of New Entrants
5.3.2 Threat of Substitutes
5.3.3 Bargaining Power of Suppliers
5.3.4 Bargaining Power of Buyers
5.3.5 Intensity of Competitive Rivalry
5.4 Regulatory Analysis
5.4.1 Regulatory Bodies, Government Agencies, and Other Organizations
5.4.1.1 North America
5.4.1.1.1 US
Table 3 Biopsy Devices Under 21 Cfr 876.1075 with Product Codes
5.4.1.2 Europe
Figure 21 Europe: Ce Mark Approval Process for Biopsy Devices
5.4.1.3 Asia-Pacific
5.4.1.3.1 Japan
Table 4 Japan: Classification of Medical Devices and Reviewing Bodies
Table 5 Nomenclature of Applicable Medical Devices with Codes
5.4.1.3.2 China
5.4.1.3.3 India
Table 6 India: Regulatory Classification for Medical Devices
5.4.1.4 Latin America
5.4.1.4.1 Brazil
Figure 22 Brazil: Regulatory Process for Medical Devices
Table 7 Brazil: Time, Cost, and Complexity of Registration Process
5.4.1.4.2 Mexico
Figure 23 Mexico: Regulatory Process for Medical Devices
Table 8 Mexico: Time, Cost, and Complexity of Registration Process
5.4.2 Regulatory Trends for Biopsy Devices Market
5.5 Reimbursement Scenario Analysis
Table 9 Medical Reimbursement Cpt Codes for Biopsy Device Procedures in Us (2021)
5.6 Ecosystem/Market Map
5.7 Value Chain Analysis
5.7.1 Research & Product Development
5.7.2 Raw Material Procurement and Manufacturing
5.7.3 Shipment, Marketing & Sales, and Post-Sales Services
Figure 24 Value Chain Analysis - Maximum Value Added During Manufacturing Phase
5.8 Supply Chain Analysis
5.8.1 Prominent Companies
5.8.2 Small and Medium-Sized Enterprises
5.8.3 End-users
Table 10 Role in Ecosystem: Biopsy Devices Market
Figure 25 Supply Chain Analysis: Biopsy Devices Market
5.9 Patent Analysis
Figure 26 Patent Details for Needle-Based Biopsy Instruments (January 2013-August 2023)
Figure 27 Patents for Biopsy Localization Wires (January 2013-August 2023)
Figure 28 Patents for Biopsy Forceps (January 2013-August 2023)
5.10 Trade Analysis
Table 11 Import Data for Biopsy Devices (Hs Code 901839), by Country, 2018-2022 (USD)
Table 12 Export Data for Biopsy Devices (Hs Code 901839), by Country, 2018-2022 (USD)
5.11 Key Stakeholders & Buying Criteria
5.11.1 Key Stakeholders in Biopsy Devices Market
Figure 29 Influence of Stakeholders on Buying Process of Biopsy Devices
Table 13 Influence of Stakeholders on Buying Process of Biopsy Devices
5.11.2 Buying Criteria for Biopsy Devices
Figure 30 Key Buying Criteria for Biopsy Devices
Table 14 Key Buying Criteria for Biopsy Devices
5.12 Key Conferences & Events (2023-2025)
Table 15 List of Key Conferences & Events, 2023-2025
5.13 Technology Analysis
5.14 Case Study Analysis
Table 16 Case Study 1: Maintaining Strong Focus on Technological Innovation and Addressing Regulatory Compliance
Table 17 Case Study 2: Providing Comprehensive Training Programs for Evolving Biopsy Techniques
5.15 Pricing Analysis
Table 18 Region-Wise Price Range for Biopsy Devices Instruments, 2023

6 Biopsy Devices Market, by Product
6.1 Introduction
Table 19 Biopsy Devices Market, by Product Type, 2021-2028 (USD Million)
6.2 Liquid Biopsy Instruments
6.2.1 Ongoing Research and Clinical Trials to Deliver Novel Solutions in Market
Table 20 Liquid Biopsy Instruments Market, by Region, 2021-2028 (USD Million)
Table 21 Liquid Biopsy Instruments Market, by Application, 2021-2028 (USD Million)
Table 22 Liquid Biopsy Instruments Market, by End-user, 2021-2028 (USD Million)
6.3 Needle-Based Biopsy Instruments
Table 23 Needle-Based Biopsy Instruments Market, by Type, 2021-2028 (USD Million)
Table 24 Needle-Based Biopsy Instruments Market, by Region, 2021-2028 (USD Million)
Table 25 Needle-Based Biopsy Instruments Market, by Application, 2021-2028 (USD Million)
Table 26 Needle-Based Biopsy Instruments Market, by End-user, 2021-2028 (USD Million)
6.3.1 Core Biopsy Devices
Table 27 Core Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 28 Core Biopsy Devices Market, by Region, 2021-2028 (USD Million)
6.3.1.1 Core Biopsy Needles
6.3.1.1.1 Greater Diagnostic Accuracy and Improved Imaging Capabilities to Boost Demand
Table 29 Core Biopsy Needles Market, by Region, 2021-2028 (USD Million)
6.3.1.2 Core Biopsy Guns
6.3.1.2.1 Rapidity, Efficiency, and Accuracy to Support Adoption
Table 30 Core Biopsy Guns Market, by Region, 2021-2028 (USD Million)
6.3.2 Aspiration Biopsy Needles
6.3.2.1 Innovations in Needle Design, Including Thinner Profiles and Improved Tip Configurations, to Drive Market
Table 31 Aspiration Biopsy Needles Market, by Region, 2021-2028 (USD Million)
6.3.3 Vacuum-Assisted Biopsy Devices
Table 32 Vacuum-Assisted Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 33 Vacuum-Assisted Biopsy Devices Market, by Region, 2021-2028 (USD Million)
6.3.3.1 Vacuum-Assisted Biopsy Systems
6.3.3.1.1 Increasing Demand for Early and Accurate Cancer Detection, Particularly in Breast Cancer, to Drive Market
Table 34 Vacuum-Assisted Biopsy Systems Market, by Region, 2021-2028 (USD Million)
6.3.3.2 Vacuum-Assisted Biopsy Needles
6.3.3.2.1 Innovative Design and Ability to Retrieve Larger Specimens to Support Adoption
Table 35 Vacuum-Assisted Biopsy Needles Market, by Region, 2021-2028 (USD Million)
6.4 Procedure Trays
6.4.1 Demand for Early Cancer Detection and Minimally Invasive Techniques to Drive Market
Table 36 Procedure Trays Market, by Region, 2021-2028 (USD Million)
Table 37 Procedure Trays Market, by Application, 2021-2028 (USD Million)
Table 38 Procedure Trays Market, by End-user, 2021-2028 (USD Million)
6.5 Localization Wires
6.5.1 Ability to Detect Precise Target Locations to Drive Market
Table 39 Localization Wires Market, by Region, 2021-2028 (USD Million)
Table 40 Localization Wires Market, by Application, 2021-2028 (USD Million)
Table 41 Localization Wires Market, by End-user, 2021-2028 (USD Million)
6.6 Biopsy Tables
6.6.1 Ease of Positioning to Drive Demand for Biopsy Tables
Table 42 Biopsy Tables Market, by Region, 2021-2028 (USD Million)
Table 43 Biopsy Tables Market, by Application, 2021-2028 (USD Million)
Table 44 Biopsy Tables Market, by End-user, 2021-2028 (USD Million)
6.7 Biopsy Forceps
Table 45 Biopsy Forceps Market, by Type, 2021-2028 (USD Million)
Table 46 Biopsy Forceps Market, by Region, 2021-2028 (USD Million)
Table 47 Biopsy Forceps Market, by Application, 2021-2028 (USD Million)
Table 48 Biopsy Forceps Market, by End-user, 2021-2028 (USD Million)
6.7.1 General Biopsy Forceps
6.7.1.1 Demand for Minimally Invasive Procedures and Precise Diagnostics Continues to Surge Market Growth
Table 49 General Biopsy Forceps Market, by Region, 2021-2028 (USD Million)
6.7.2 Hot Biopsy Forceps
6.7.2.1 Unique Ability to Cut and Coagulate Tissue Simultaneously to Support Adoption
Table 50 Hot Biopsy Forceps Market, by Region, 2021-2028 (USD Million)
6.8 Other Products
Table 51 Other Biopsy Products Market, by Region, 2021-2028 (USD Million)
Table 52 Other Biopsy Products Market, by Application, 2021-2028 (USD Million)
Table 53 Other Biopsy Products Market, by End-user, 2021-2028 (USD Million)

7 Biopsy Devices Market, by Guidance Technique
7.1 Introduction
Table 54 Biopsy Devices Market, by Guidance Technique, 2021-2028 (USD Million)
7.2 Non-Image-Guided Biopsy
7.2.1 Wide Usage in Situations Where Imaging Technology is Inaccessible to Drive Market
Table 55 Non-Image-Guided Biopsy Market, by Region, 2021-2028 (USD Million)
7.3 Image-Guided Biopsy
Table 56 Image-Guided Biopsy Market, by Type, 2021-2028 (USD Million)
Table 57 Image-Guided Biopsy Market, by Region, 2021-2028 (USD Million)
7.3.1 Ultrasound-Guided Biopsy
7.3.1.1 Advantages of Technique to Boost Usage
Table 58 Ultrasound-Guided Biopsy Market, by Region, 2021-2028 (USD Million)
7.3.2 Stereotactic-Guided Biopsy
7.3.2.1 Efficiency and Accuracy to Support Adoption
Table 59 Stereotactic-Guided Biopsy Market, by Region, 2021-2028 (USD Million)
7.3.3 Mri-Guided Biopsy
7.3.3.1 High Cost and Low Specificity to Affect Demand
Table 60 Mri-Guided Biopsy Market, by Region, 2021-2028 (USD Million)
7.3.4 Other Image-Guided Biopsy Techniques
Table 61 Other Image-Guided Biopsy Techniques Market, by Region, 2021-2028 (USD Million)

8 Biopsy Devices Market, by Application
8.1 Introduction
Table 62 Biopsy Devices Market, by Application, 2021-2028 (USD Million)
8.2 Lung Cancer
8.2.1 Lung Cancer to Hold Largest Market Share
Table 63 Biopsy Devices Market for Lung Cancer, by Region, 2021-2028 (USD Million)
8.3 Breast Cancer
8.3.1 Increasing Demand for Early and Accurate Diagnosis and Rising Prevalence to Drive Market
Table 64 Biopsy Devices Market for Breast Cancer, by Region, 2021-2028 (USD Million)
8.4 Colorectal Cancer
8.4.1 Rising Emphasis on Early Detection and Screening to Support Market Growth
Table 65 Biopsy Devices Market for Colorectal Cancer, by Region, 2021-2028 (USD Million)
8.5 Kidney Cancer
8.5.1 Advancements in Diagnostics and Growing Emphasis on Cancer Therapeutics to Drive Market
Table 66 Biopsy Devices Market for Kidney Cancer, by Region, 2021-2028 (USD Million)
8.6 Prostate Cancer
8.6.1 Rising Incidence of Prostate Cancer and Growing Aging Population to Support Demand for Biopsy Devices
Table 67 Biopsy Devices Market for Prostate Cancer, by Region, 2021-2028 (USD Million)
8.7 Bone Marrow Biopsy
8.7.1 Rising Emphasis on Bone Marrow Biopsies to Support Market Growth
Table 68 Biopsy Devices Market for Bone Marrow Biopsy, by Region, 2021-2028 (USD Million)
8.8 Other Applications
Table 69 Biopsy Devices Market for Other Applications, by Region, 2021-2028 (USD Million)

9 Biopsy Devices Market, by End-user
9.1 Introduction
Table 70 Biopsy Devices Market, by End-user, 2021-2028 (USD Million)
9.2 Hospitals & Breast Care Centers
9.2.1 High Procedural Volumes to Ensure Sustained Demand for Biopsy Devices
Table 71 Biopsy Devices Market for Hospitals & Breast Care Centers, by Region, 2021-2028 (USD Million)
9.3 Diagnostic Imaging Centers
9.3.1 Increasing Number of Private Imaging Centers to Support Market Growth
Table 72 Biopsy Devices Market for Diagnostic Imaging Centers, by Region, 2021-2028 (USD Million)
9.4 Academic & Research Institutes
9.4.1 Growing Availability of Research Grants and Funding to Drive Market
Table 73 Biopsy Devices Market for Academic & Research Institutes, by Region, 2021-2028 (USD Million)
9.5 Other End-users
Table 74 Biopsy Devices Market for Other End-users, by Region, 2021-2028 (USD Million)

10 Biopsy Devices Market, by Region
10.1 Introduction
Table 75 Biopsy Devices Market, by Region, 2021-2028 (USD Million)
10.2 North America
10.2.1 Recession Impact
Figure 31 North America: Biopsy Devices Market Snapshot
Table 76 North America: Biopsy Devices Market, by Country, 2021-2028 (USD Million)
Table 77 North America: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
Table 78 North America: Needle-Based Biopsy Instruments Market, by Type, 2021-2028 (USD Million)
Table 79 North America: Core Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 80 North America: Vacuum-Assisted Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 81 North America: Biopsy Forceps Market, by Type, 2021-2028 (USD Million)
Table 82 North America: Biopsy Devices Market, by Application, 2021-2028 (USD Million)
Table 83 North America: Biopsy Devices Market, by End-user, 2021-2028 (USD Million)
10.2.2 US
10.2.2.1 Rising Geriatric Population to Drive Market
Table 84 US: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.2.3 Canada
10.2.3.1 Government Investments to Support Market Growth
Table 85 Canada: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.3 Europe
10.3.1 Recession Impact
Table 86 Europe: Biopsy Devices Market, by Country, 2021-2028 (USD Million)
Table 87 Europe: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
Table 88 Europe: Needle-Based Biopsy Instruments Market, by Type, 2021-2028 (USD Million)
Table 89 Europe: Core Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 90 Europe: Vacuum-Assisted Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 91 Europe: Biopsy Forceps Market, by Type, 2021-2028 (USD Million)
Table 92 Europe: Biopsy Devices Market, by Application, 2021-2028 (USD Million)
Table 93 Europe: Biopsy Devices Market, by End-user, 2021-2028 (USD Million)
10.3.2 Germany
10.3.2.1 Increasing Prevalence of Chronic Diseases to Propel Market
Table 94 Germany: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.3.3 France
10.3.3.1 Rising Number of Diagnostic Imaging Centers to Drive Market
Table 95 France: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.3.4 UK
10.3.4.1 Government Initiatives to Support Market Growth
Table 96 UK: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.3.5 Italy
10.3.5.1 Availability of Reimbursement Coverage to Support Market Growth
Table 97 Italy: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.3.6 Spain
10.3.6.1 Increasing Focus on Cancer Research to Propel Market
Table 98 Spain: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.3.7 Rest of Europe
Table 99 Rest of Europe: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.4 Asia-Pacific
10.4.1 Recession Impact
Figure 32 Asia-Pacific: Biopsy Devices Market Snapshot
Table 100 Asia-Pacific: Biopsy Devices Market, by Country, 2021-2028 (USD Million)
Table 101 Asia-Pacific: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
Table 102 Asia-Pacific: Needle-Based Biopsy Instruments Market, by Type, 2021-2028 (USD Million)
Table 103 Asia-Pacific: Core Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 104 Asia-Pacific: Vacuum-Assisted Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 105 Asia-Pacific: Biopsy Forceps Market, by Type, 2021-2028 (USD Million)
Table 106 Asia-Pacific: Biopsy Devices Market, by Application, 2021-2028 (USD Million)
Table 107 Asia-Pacific: Biopsy Devices Market, by End-user, 2021-2028 (USD Million)
10.4.2 China
10.4.2.1 Rapidly Growing Geriatric Population to Propel Market
Table 108 China: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.4.3 Japan
10.4.3.1 High Adoption of Advanced Technologies to Support Market Growth
Table 109 Japan: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.4.4 India
10.4.4.1 Rising Prevalence of Chronic Diseases to Drive Market
Table 110 India: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.4.5 Australia
10.4.5.1 Increasing Investments in Research to Provide Opportunities for Market Growth
Table 111 Australia: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.4.6 South Korea
10.4.6.1 Presence of Well-Developed Healthcare System to Propel Market
Table 112 South Korea: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.4.7 Rest of Asia-Pacific
Table 113 Rest of Asia-Pacific: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.5 Latin America
10.5.1 Recession Impact
Table 114 Latin America: Biopsy Devices Market, by Country, 2021-2028 (USD Million)
Table 115 Latin America: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
Table 116 Latin America: Needle-Based Biopsy Instruments Market, by Type, 2021-2028 (USD Million)
Table 117 Latin America: Core Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 118 Latin America: Vacuum-Assisted Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 119 Latin America: Biopsy Forceps Market, by Type, 2021-2028 (USD Million)
Table 120 Latin America: Biopsy Devices Market, by Application, 2021-2028 (USD Million)
Table 121 Latin America: Biopsy Devices Market, by End-user, 2021-2028 (USD Million)
10.5.2 Brazil
10.5.2.1 Favorable Demographic Conditions to Drive Market
Table 122 Brazil: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.5.3 Mexico
10.5.3.1 Increased Medical Tourism and Better Government Healthcare Initiatives to Drive Market
Table 123 Mexico: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.5.4 Rest of Latin America
Table 124 Rest of Latin America: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
10.6 Middle East & Africa
10.6.1 Growing Medical Tourism to Drive Market
10.6.2 Recession Impact
Table 125 Middle East & Africa: Biopsy Devices Market, by Product, 2021-2028 (USD Million)
Table 126 Middle East & Africa: Needle-Based Biopsy Instruments Market, by Type, 2021-2028 (USD Million)
Table 127 Middle East & Africa: Core Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 128 Middle East & Africa: Vacuum-Assisted Biopsy Devices Market, by Type, 2021-2028 (USD Million)
Table 129 Middle East & Africa: Biopsy Forceps Market, by Type, 2021-2028 (USD Million)
Table 130 Middle East & Africa: Biopsy Devices Market, by Application, 2021-2028 (USD Million)
Table 131 Middle East & Africa: Biopsy Devices Market, by End-user, 2021-2028 (USD Million)

11 Competitive Landscape
11.1 Overview
11.2 Key Players Strategies
11.2.1 Overview of Strategies Adopted by Players in Biopsy Devices Market
11.3 Revenue Share Analysis
Figure 33 Top Five Players Have Dominated Market in Last Five Years
11.4 Market Share Analysis
11.4.1 Needle-Based Biopsy Devices Market
Figure 34 Market Share Analysis of Top Players in Biopsy Devices Market (2022)
Table 132 Intensity of Competitive Rivalry for Needle-Based Devices and Accessories Market Players
11.4.2 Liquid Biopsy Market
Figure 35 Market Share Analysis of Top Players in Liquid Biopsy Market (2022)
Table 133 Intensity of Competitive Rivalry for Liquid Biopsy Market Players
11.5 Company Evaluation Matrix for Key Players (2022)
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
Figure 36 Biopsy Devices Market: Company Evaluation Matrix for Key Players (2022)
11.5.5 Competitive Benchmarking
Table 134 Biopsy Devices Market: Product and Regional Footprint Analysis of Companies
Table 135 Biopsy Devices Market-Product Footprint Analysis of Companies for Key Players
Table 136 Biopsy Devices Market- Regional Footprint Analysis of Key Companies
11.6 Start-Up/Sme Evaluation Matrix (2022)
11.6.1 Progressive Companies
11.6.2 Responsive Companies
11.6.3 Dynamic Companies
11.6.4 Starting Blocks
Figure 37 Biopsy Devices Market: Company Evaluation Matrix for Start-Ups/Smes (2022)
11.6.5 Competitive Benchmarking for Start-Ups/Smes
Table 137 Biopsy Devices Market: Product & Regional Footprint Analysis of Companies
Table 138 Biopsy Devices Market-Product Footprint Analysis of Companies for Start-Up/Sme Players
Table 139 Biopsy Devices Market- Regional Footprint Analysis of Start-Up/Sme Companies
11.7 Competitive Scenarios and Trends
Table 140 Biopsy Devices Market: Product Launches (January 2020-August 2023)
Table 141 Biopsy Devices Market: Deals (January 2020-August 2023)
Table 142 Biopsy Devices Market: Other Developments (January 2020-August 2023)

12 Company Profiles
12.1 Key Players
(Business Overview, Products Offered, Recent Developments, Analyst's View, Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats)*
12.1.1 Becton, Dickinson and Company
Table 143 Becton, Dickinson and Company: Business Overview
Figure 38 Becton, Dickinson and Company: Company Snapshot (2022)
12.1.2 Devicor Medical Products, Inc. (Part of Danaher Corporation)
Table 144 Danaher Corporation: Business Overview
Figure 39 Danaher Corporation: Company Snapshot (2022)
12.1.3 B. Braun Melsungen Ag
Table 145 B. Braun Melsungen Ag: Business Overview
Figure 40 B. Braun Melsungen Ag: Company Snapshot (2022)
12.1.4 Cardinal Health, Inc.
Table 146 Cardinal Health, Inc.: Business Overview
Figure 41 Cardinal Health, Inc.: Company Snapshot (2022)
12.1.5 Hologic, Inc.
Table 147 Hologic, Inc.: Business Overview
Figure 42 Hologic, Inc.: Company Snapshot (2022)
12.1.6 Olympus Corporation
Table 148 Olympus Corporation: Business Overview
Figure 43 Olympus Corporation: Company Snapshot (2022)
12.1.7 Boston Scientific Corporation
Table 149 Boston Scientific Corporation: Business Overview
Figure 44 Boston Scientific Corporation: Company Snapshot (2022)
12.1.8 Fujifilm Corporation
Table 150 Fujifilm Corporation: Business Overview
Figure 45 Fujifilm Corporation: Company Snapshot (2022)
12.1.9 Medtronic plc
Table 151 Medtronic plc: Business Overview
Figure 46 Medtronic plc: Company Snapshot (2022)
12.1.10 Stryker Corporation
Table 152 Stryker Corporation: Business Overview
Figure 47 Stryker: Company Snapshot (2022)
12.1.11 Cook Group Incorporated
Table 153 Cook Group Incorporated: Business Overview
12.1.12 Argon Medical Devices
Table 154 Argon Medical Devices: Business Overview
12.1.13 Inrad, Inc.
Table 155 Inrad, Inc.: Business Overview
12.1.14 Conmed Corporation
Table 156 Conmed Corporation: Business Overview
12.1.15 Teleflex Incorporated
Table 157 Teleflex Incorporated.: Business Overview
Figure 48 Teleflex Incorporated: Company Snapshot (2022)
12.1.16 Qiagen N.V.
Table 158 Qiagen N.V.: Business Overview
Figure 49 Qiagen N.V.: Company Snapshot (2022)
12.1.17 Thermo Fisher Scientific, Inc.
Table 159 Thermo Fisher Scientific, Inc.: Business Overview
Figure 50 Thermo Fisher Scientific, Inc.: Company Snapshot (2022)
12.2 Other Players
12.2.1 Summit Medical LLC
12.2.2 Hill-Rom Holdings, Inc.
12.2.3 Gallini S.R.L
12.2.4 Transmed7, LLC
12.2.5 Tsk Laboratory International
12.2.6 Merit Medical Systems, Inc.
12.2.7 Dr. Japan Co., Ltd.
12.2.8 Izi Medical Products
12.2.9 Planmed Oy
12.2.10 Advin Health Care
12.2.11 F. Hoffmann-La Roche Ltd.
12.2.12 Bio-Rad Laboratories, Inc.
12.2.13 Illumina, Inc.
*Details on Business Overview, Products Offered, Recent Developments, Analyst's View, Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats Might Not be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Companies Mentioned

  • Advin Health Care
  • Argon Medical Devices
  • B. Braun Melsungen Ag
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Conmed Corporation
  • Cook Group Incorporated
  • Devicor Medical Products, Inc. (Part of Danaher Corporation)
  • Dr. Japan Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Corporation
  • Gallini S.R.L
  • Hill-Rom Holdings, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Inrad, Inc.
  • Izi Medical Products
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Olympus Corporation
  • Planmed Oy
  • Qiagen N.V.
  • Stryker Corporation
  • Summit Medical LLC
  • Teleflex Incorporated
  • Thermo Fisher Scientific, Inc.
  • Transmed7, LLC
  • Tsk Laboratory International

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages229
PublishedOctober 2023
Forecast Period2023 - 2028
Estimated Market Value ( USD ) in 2023 $ 6.6 Billion
Forecasted Market Value ( USD ) by 2028 $ 12.6 Billion
Compound Annual Growth Rate14.0%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Biopsy Devices Global Market Report 2024 - Product Image

Biopsy Devices Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Biopsy Devices Market by Product, Technique, Application, End User - Global Forecast 2025-2030 - Product Image

Biopsy Devices Market by Product, Technique, Application, End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Biopsy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Biopsy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2024-2032 - Product Image

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Biopsy Devices Market Analysis & Forecast to 2024-2034 - Product Image

Biopsy Devices Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.